SOON-DUCK LEE: Open Payments
NPI 1609396258 · BRONX, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,655 in 43 payments from 9 companies in 2025. Trend: 2023 $1,201 · 2024 $1,154 · 2025 $1,655
Food & beverage: $1,655
| Company | Payments | Amount |
|---|---|---|
| Intra-Sana Laboratories | 15 | $570 |
| Novo Nordisk Inc | 4 | $294 |
| HEARTFLOW, INC. | 2 | $278 |
| Novartis Pharmaceuticals Corporation | 13 | $252 |
| Lilly USA, LLC | 2 | $134 |
| Merck Sharp & Dohme LLC | 3 | $46 |
| PFIZER INC. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| Amgen Inc. | 1 | $20 |
Products named: RELTONE 200 MG, FFRct, LEQVIO, Wegovy, ELIQUIS, VERQUVO, MOUNJARO, GLYCATE.
Industry payments across NY — which companies pay providers there.
